Abstract:Rationale: Developing an effective nanoplatform to realize 'multi-in-one' is essential to broaden the therapeutic potential of combination therapy. Exosomes are ideal candidates since their intrinsic abilities of integrating multiple contents and functions. However, only limited efforts have been devoted to engineering exosomes to integrate the needed properties, also considering the safety and yield, for tumor-targeted and efficient gene/chemo combination therapy.Methods: Herein, by manipulating the exosome membrane, blood exosomes with high abundance and safety are engineered as a versatile combinatorial delivery system, where the doxorubicin (Dox) and cholesterol-modified miRNA21 inhibitor (miR-21i) are co-embedded into the lipid bilayer of exosomes, and the magnetic molecules and endosomolytic peptides L17E are bind to the exosome membrane through ligand-receptor coupling and electrostatic interactions, respectively.Results: It is proved that such engineering strategy not only preserves their intrinsic features, but also readily integrates multiple properties of tumor targeting, efficient transfection and gene/chemo combination therapy into blood exosomes. The lipid bilayer structure of exosomes allows them to co-load Dox and miR-21i with high-payloads. Moreover, profiting from the integration of magnetic molecules and L17E peptides, the engineered exosomes exhibit an enhanced tumor accumulation and an improved endosome escape ability, thereby specifically and efficiently delivering encapsulated cargos to tumor cells. As a result, a remarkable inhibition of tumor growth is observed in the tumor-bearing mice, and without noticeable side effects.Conclusions: This study demonstrates the potential of engineered blood exosomes as feasible co-delivery nanosystem for tumor-targeted and efficient combination therapy. Further development by replacing the drugs combined regimens can potentially make this engineered exosome become a general platform for the design of safe and effective combination therapy modality.

Engineered exosomes as a natural nanoplatform for cancer targeted delivery of metal-based drugs

Engineered Exosomes as Theranostic Platforms for Cancer Treatment

Advances in engineered exosomes towards cancer diagnosis and therapeutics

Application of exosome engineering modification in targeted delivery of therapeutic drugs

Engineered exosomes from different sources for cancer-targeted therapy

Engineering exosomes for targeted drug delivery

Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy

Engineered Exosomes for Tumor-Targeted Drug Delivery: A Focus on Genetic and Chemical Functionalization

Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells.

Exosome-Based Delivery of Natural Products in Cancer Therapy

Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence

Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics

Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies

Engineering exosomes as refined biological nanoplatforms for drug delivery

Biomembrane and metal nanostructures for cancer theranostics: The state of the art in the combination of organic and inorganic chemistry

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.

Shape Engineering of Exosomes for Endoplasmic Reticulum-Targeted Delivery and Amplified Anticancer Efficacy

Exosomes as Drug Carriers in Anti-Cancer Therapy

Cancer cell-derived exosome based dual-targeted drug delivery system for non-small cell lung cancer therapy

Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake

Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate